The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
NK Cell Metabolism and Tumor Microenvironment
Open accessAbstract
Natural Killer (NK) cells are characterized by their potential to kill tumor cells by different means without previous sensitization and have, therefore, become a valuable tool in cancer immunotherapy. However, their efficacy against solid tumors is still poor and further studies are required to improve it. One of the major restrictions for NK cell activity is the immunosuppressive tumor microenvironment (TME). There, tumor and other immune cells create the appropriate conditions for tumor proliferation while, among others, preventing NK cell activation. Furthermore, NK cell metabolism is impaired in the TME, presumably due to nutrient and oxygen deprivation, and the higher concentration of tumor-derived metabolic end products, such as lactate. This metabolic restriction of NK cells limits their effector functions, and it could represent a potential target to focus on to improve the efficacy of NK cell-based therapies against solid tumors. In this review, we discuss the potential effect of TME into NK cell metabolism and its influence in NK cell effector functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 721
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Viel, S., Marçais, A., Guimaraes, F. S.-F., Loftus, R., Rabilloud, J., Grau, M., Degouve, S., Djebali, S., Sanlaville, A., Charrier, E., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad1884 · Cited by 672
Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
Michelet, X., Dyck, L., Hogan, A., Loftus, R. M., Duquette, D., Wei, K., Beyaz, S., Tavakkoli, A., Foley, C., Donnelly, R., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0251-7 · Cited by 621
Marçais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2936 · Cited by 614
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Cascone, T., McKenzie, J. A., Mbofung, R. M., Punt, S., Wang, Z., Xu, C., Williams, L. J., Wang, Z., Bristow, C. A., Carugo, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.024 · Cited by 611
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Liu, X., Shin, N., Koblish, H. K., Yang, G., Wang, Q., Wang, K., Leffet, L., Hansbury, M. J., Thomas, B., Rupar, M., et al. (2010) · Blood · doi:10.1182/blood-2009-09-246124 · Cited by 548
MacIver, N. J., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Coloff, J. L., & Rathmell, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108024 · Cited by 505
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Donnelly, R. P., Loftus, R. M., Keating, S. E., Liou, K. T., Biron, C. A., Gardiner, C. M., & Finlay, D. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401558 · Cited by 485
Immunometabolism and natural killer cell responses
O’Brien, K. L., & Finlay, D. K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0139-2 · Cited by 435
Effect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 399
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Young, A., Ngiow, S. F., Gao, Y., Patch, A.-M., Barkauskas, D. S., Messaoudene, M., Lin, G., Coudert, J. D., Stannard, K. A., Zitvogel, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2826 · Cited by 391
Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838289 · Cited by 388 · cited 1×
“It has been demonstrated that glucose deprivation dampens T cell antitumor activity (46, 55, 56), and that metabolic competition in the TME can regulate cancer progression by impairing antigen-specific responses of tumorinfiltrating T cells (57).”
BackgroundA Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
Ohta, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00109 · Cited by 385
Loftus, R. M., Assmann, N., Kedia-Mehta, N., O’Brien, K. L., Garcia, A., Gillespie, C., Hukelmann, J. L., Oefner, P. J., Lamond, A. I., Gardiner, C. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04719-2 · Cited by 381
Cong, J., Wang, X., Zheng, X., Wang, D., Fu, B., Sun, R., Tian, Z., & Wei, H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.021 · Cited by 380
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3838 · Cited by 375
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 374
Harmon, C., Robinson, M. W., Hand, F., Almuaili, D., Mentor, K., Houlihan, D. D., Hoti, E., Lynch, L., Geoghegan, J., & O'Farrelly, C. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0481 · Cited by 360
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.006 · Cited by 358
Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304790110 · Cited by 344
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Li, T., Yang, Y., Hua, X., Wang, G., Liu, W., Jia, C., Tai, Y., Zhang, Q., & Chen, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.020 · Cited by 328
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
Keating, S. E., Zaiatz-Bittencourt, V., Loftus, R. M., Keane, C., Brennan, K., Finlay, D. K., & Gardiner, C. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501783 · Cited by 325
Bi, J., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00760 · Cited by 325
Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
Keppel, M. P., Saucier, N., Mah, A. Y., Vogel, T. P., & Cooper, M. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402099 · Cited by 313
NK cell-based immunotherapy for cancer
Fang, F., Xiao, W., & Tian, Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.009 · Cited by 306
Targeting amino acid metabolism for cancer therapy
Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.003 · Cited by 293
Competition for nutrients and its role in controlling immune responses
Kedia-Mehta, N., & Finlay, D. K. (2019) · Nature Communications · doi:10.1038/s41467-019-10015-4 · Cited by 287
Balsamo, M., Manzini, C., Pietra, G., Raggi, F., Blengio, F., Mingari, M. C., Varesio, L., Moretta, L., Bosco, M. C., & Vitale, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343448 · Cited by 282
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Felices, M., Lenvik, A. J., McElmurry, R., Chu, S., Hinderlie, P., Bendzick, L., Geller, M. A., Tolar, J., Blazar, B. R., & Miller, J. S. (2018) · JCI Insight · doi:10.1172/jci.insight.96219 · Cited by 272
Schurich, A., Pallett, L. J., Jajbhay, D., Wijngaarden, J., Otano, I., Gill, U. S., Hansi, N., Kennedy, P. T., Nastouli, E., Gilson, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.078 · Cited by 256
Glucose transporter expression on the plasma membrane of resting and activated white blood cells
Maratou, E., Dimitriadis, G., Kollias, A., Boutati, E., Lambadiari, V., Mitrou, P., & Raptis, S. A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01786.x · Cited by 251
Stiff, A., Trikha, P., Mundy-Bosse, B., McMichael, E., Mace, T. A., Benner, B., Kendra, K., Campbell, A., Gautam, S., Abood, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0691 · Cited by 244
Targeting natural killer cells in solid tumors
Habif, G., Crinier, A., André, P., Vivier, E., & Narni-Mancinelli, E. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0224-2 · Cited by 241
Sarkar, S., Germeraad, W. T. V., Rouschop, K. M. A., Steeghs, E. M. P., Gelder, M. V., Bos, G. M. J., & Wieten, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064835 · Cited by 215
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Becker, P. S. A., Suck, G., Nowakowska, P., Ullrich, E., Seifried, E., Bader, P., Tonn, T., & Seidl, C. (2016) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1792-y · Cited by 208
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Sek, K., Mølck, C., Stewart, G. D., Kats, L., Darcy, P. K., & Beavis, P. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123837 · Cited by 204
Baginska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 198
The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
Nandagopal, N., Ali, A. K., Komal, A. K., & Lee, S.-H. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00187 · Cited by 196
Single cell analysis of kynurenine and System L amino acid transport in T cells
Sinclair, L. V., Neyens, D., Ramsay, G., Taylor, P. M., & Cantrell, D. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04366-7 · Cited by 193
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Granzin, M., Wagner, J., Köhl, U., Cerwenka, A., Huppert, V., & Ullrich, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00458 · Cited by 181
Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism
Zaiatz-Bittencourt, V., Finlay, D. K., & Gardiner, C. M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701461 · Cited by 177
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Nayyar, G., Chu, Y., & Cairo, M. S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00051 · Cited by 177
Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells
Raskovalova, T., Huang, X., Sitkovsky, M., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4383 · Cited by 175
Mao, Y., van Hoef, V., Zhang, X., Wennerberg, E., Lorent, J., Witt, K., Masvidal, L., Liang, S., Murray, S., Larsson, O., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698027 · Cited by 172
Dong, H., Adams, N. M., Xu, Y., Cao, J., Allan, D. S. J., Carlyle, J. R., Chen, X., Sun, J. C., & Glimcher, L. H. (2019) · Nature Immunology · doi:10.1038/s41590-019-0388-z · Cited by 172
Park, A., Lee, Y., Kim, M. S., Kang, Y. J., Park, Y.-J., Jung, H., Kim, T.-D., Lee, H. G., Choi, I., & Yoon, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01859 · Cited by 163
Metabolic Regulation of Natural Killer Cell IFN-γ Production
Mah, A. Y., & Cooper, M. A. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016017387 · Cited by 161
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
Hasmim, M., Messai, Y., Ziani, L., Thiery, J., Bouhris, J.-H., Noman, M. Z., & Chouaïb, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00482 · Cited by 160
Joseph, L. C., Kokkinaki, D., Valenti, M.-C., Kim, G. J., Barca, E., Tomar, D., Hoffman, N. E., Subramanyam, P., Colecraft, H. M., Hirano, M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94248 · Cited by 159
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Zhang, C., Wang, X., Li, S.-R., Twelkmeyer, T., Wang, W., Zhang, S.-Y., Wang, S., Chen, J., Jin, X., Wu, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09212-y · Cited by 154
Regulation of NK Cell Function by Human Granulocyte Arginase
Oberlies, J., Watzl, C., Giese, T., Luckner, C., Kropf, P., Müller, I., Ho, A. D., & Munder, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803523 · Cited by 153
Parodi, M., Raggi, F., Cangelosi, D., Manzini, C., Balsamo, M., Blengio, F., Eva, A., Varesio, L., Pietra, G., Moretta, L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02358 · Cited by 151
ARID5B regulates metabolic programming in human adaptive NK cells
Cichocki, F. M., Wu, C., Zhang, B., Felices, M., Tesi, B., Tuininga, K., Dougherty, P., Taras, E., Hinderlie, P., Blazar, B. R., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172168 · Cited by 150
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control
Mah-Som, A. Y., Rashidi, A., Keppel, M. P., Saucier, N., Moore, E. K., Alinger, J. B., Tripathy, S. K., Agarwal, S. K., Jeng, E. K., Wong, H. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95128 · Cited by 142
Jin, F., Zhaozhen, W., Hu, X., Zhang, J., Zihe, G., Xiao, H., Junfang, Q., Chen, L., & Wang, Y. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0253 · Cited by 142
Lokshin, A. E., Raskovalova, T., Huang, X., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0478 · Cited by 138
Altered functions of natural killer cells in response to L-Arginine availability
Lamas, B., Vergnaud, J., Gonçalves-Mendes, N., Perche, O., Rossary, A., Vasson, M., & Farges, M. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.018 · Cited by 136
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
Chambers, A. M., Wang, J., Lupo, K. B., Yu, H., Lanman, N. A., & Matosevic, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02533 · Cited by 136
Wang, F., Meng, M., Mo, B., Yang, Y., Ji, Y., Huang, P., Lai, W., Pan, X., You, T., Luo, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07277-9 · Cited by 133
NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient
Tobin, L. M., Mavinkurve, M., Carolan, E., Kinlen, D., O’Brien, E. C., Little, M. A., Finlay, D. K., Cody, D., Hogan, A. E., & O'Shea, D. B. (2017) · JCI Insight · doi:10.1172/jci.insight.94939 · Cited by 128
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Parameswaran, R., Ramakrishnan, P., Moreton, S. A., Xia, Z., Hou, Y., Lee, D. A., Gupta, K., Lima, M. J. G. D., Beck, R. C., & Wald, D. N. (2016) · Nature Communications · doi:10.1038/ncomms11154 · Cited by 121
Müller-Durovic, B., Lanna, A., Covre, L. P., Mills, R. S., Henson, S. M., & Akbar, A. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600590 · Cited by 113
Shaping of NK Cell Responses by the Tumor Microenvironment
Stojanovic, A., Correia, M. P., & Cerwenka, A. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0125-8 · Cited by 105
Huenecke, S., Zimmermann, S. Y., Kloeß, S., Esser, R., Brinkmann, A., Tramsen, L., Koenig, M., Erben, S., Seidl, C., Tonn, T., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181bb46f7 · Cited by 104
Gardiner, C. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-260r · Cited by 102
Jensen, H., Potempa, M., Gotthardt, D., & Lanier, L. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700497 · Cited by 89
di Vito, C., Mikulak, J., Zaghi, E., Pesce, S., Marcenaro, E., & Mavilio, D. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.004 · Cited by 88
Schafer, J. R., Salzillo, T. C., Chakravarti, N., Kararoudi, M. N., Trikha, P., Foltz, J. A., Wang, R., Li, S., & Lee, D. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.047 · Cited by 87
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 86
Velásquez, S. Y., Killian, D., Schulte, J., Sticht, C., Thiel, M., & Lindner, H. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721753 · Cited by 85
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
Chambers, A. M., Lupo, K. B., & Matosevic, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02517 · Cited by 85
Salzberger, W., Martrus, G., Bachmann, K. A., Goebels, H., Hess, L. U., Koch, M., Langeneckert, A. E., Lunemann, S., Oldhafer, K. J., Pfeifer, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201170 · Cited by 78
Nutrient sensing, signal transduction and immune responses
Walls, J. F., Sinclair, L. V., & Finlay, D. K. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.001 · Cited by 75
Almutairi, S. M., Ali, A. K., He, W. R., Yang, D.-S., Ghorbani, P., Wang, L., Fullerton, M. D., & Lee, S.-H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005892 · Cited by 75
Ewen, E., Pahl, J. H. W., Miller, M., Watzl, C., & Cerwenka, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201747128 · Cited by 70
Castro, W., Chelbi, S. T., Niogret, C., Ramón-Barros, C., Welten, S. P. M., Osterheld, K., Wang, H., Rota, G., Morgado, L., Vivier, É., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0144-9 · Cited by 65
Fink, T., Ebbesen, P., Koppelhus, U., & Zachar, V. (2003) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2003.01347.x · Cited by 60
Burrows, N., & Maxwell, P. H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.019 · Cited by 57
Terrén, I., Mikelez-Alonso, I., Odriozola, I., Gredilla, A., González, J., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00737 · Cited by 54
Self-citationDiacylglycerol Kinase ζ Is a Target To Enhance NK Cell Function
Yang, E., Singh, B. K., Schmidt, A. M., & Kambayashi, T. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600581 · Cited by 49
Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells
Viel, S., Besson, L., Marotel, M., Walzer, T., & Marçais, A. (2017) · Cancers · doi:10.3390/cancers9100132 · Cited by 45
Natural killer cell metabolism
Kobayashi, T., & Mattarollo, S. R. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.021 · Cited by 45
Guo, F., Hong, W., Yang, M., Xu, D., Bai, Q., Li, X., & Chen, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.058 · Cited by 43
Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile
Pfeifer, C., Highton, A., Peine, S., Sauter, J., Schmidt, A., Bunders, M., Altfeld, M., & Körner, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03020 · Cited by 42
Rossin, D., Dias, I. H. K., Solej, M., Milic, I., Pitt, A. R., Iaia, N., Scoppapietra, L., Devitt, A., Nano, M., Degiuli, M., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.020 · Cited by 41
Li, D., Long, W., Huang, R., Chen, Y., & Xia, M. (2018) · Obesity · doi:10.1002/oby.22130 · Cited by 33
Piątkiewicz, P., Bernat-Karpińska, M., Miłek, T., Rabijewski, M., & Rosiak, E. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0152-6 · Cited by 23
Endospanin-2 enhances skeletal muscle energy metabolism and running endurance capacity
Lancel, S., Hesselink, M. K. C., Woldt, E., Rouillé, Y., Dorchies, E., Delhaye, S., Duhem, C., Thorel, Q., Mayeuf-Louchart, A., Pourcet, B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98081 · Cited by 17
Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma
Zenarruzabeitia, O., Vitallé, J., Astigarraga, I., & Borrego, F. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2478 · Cited by 15
Self-citation
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J.-K., Choi, Y.-K., & Park, K.-G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 550
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
Metadata
- Authors
- Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-09-24
- Volume
- 10
- Pages
- 2278-2278
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2977041418
- Cited by
- 501
- References
- 107
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.